跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACETAMINOPHEN LIQUID GEL CAPSULES - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACETAMINOPHEN LIQUID GEL CAPSULES
Authorized
STANDARD
ACETAMINOPHEN LIQUID GEL CAPSULES
Apotex Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
38be696db71be81e
Company
Apotex Inc
Type
Standard
Approval Details
Approval Id
38be696db71be81e
Drug Approval Canada Name
ACETAMINOPHEN LIQUID GEL CAPSULES
Product Name
ACETAMINOPHEN LIQUID GEL CAPSULES
Status
Dormant
Status Date
2020-07-31
Original Market Date
2017-05-10
Din
02450917
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
OTC
Ahfs
28:08.92
Atc Original
N02BE01 ACETAMINOPHEN (PARACETAMOL)
Atc Name
n 02 be 01
Aig Number
0102009001
Company Name
Apotex Inc
Company Address
150 Signet Drive, Toronto, Ontario, Canada, M9L 1T9
Company Detail Path
/organization/apotex-inc
Company Information
Pharmaceutical Company Name
Apotex Inc
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
150 Signet Dr
Active Ingredients
ACETAMINOPHEN
325 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
38be696db71be81e
Type
Standard
Back to Health Canada Approvals